Jiangxi Synergy Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Jiangxi Synergy Pharmaceutical has a total shareholder equity of CN¥2.3B and total debt of CN¥916.9M, which brings its debt-to-equity ratio to 40.4%. Its total assets and total liabilities are CN¥3.4B and CN¥1.1B respectively. Jiangxi Synergy Pharmaceutical's EBIT is CN¥98.0M making its interest coverage ratio -7.6. It has cash and short-term investments of CN¥639.6M.
Key information
40.4%
Debt to equity ratio
CN¥916.92m
Debt
Interest coverage ratio | -7.6x |
Cash | CN¥639.63m |
Equity | CN¥2.27b |
Total liabilities | CN¥1.12b |
Total assets | CN¥3.39b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300636's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥672.1M).
Long Term Liabilities: 300636's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥447.3M).
Debt to Equity History and Analysis
Debt Level: 300636's net debt to equity ratio (12.2%) is considered satisfactory.
Reducing Debt: 300636's debt to equity ratio has increased from 9% to 40.4% over the past 5 years.
Debt Coverage: 300636's debt is not well covered by operating cash flow (11.8%).
Interest Coverage: 300636 earns more interest than it pays, so coverage of interest payments is not a concern.